Majdi Halabi, MD

Original Contribution

Comparison of Two Platelet Glycoprotein IIb/IIIa Inhibitors, Eptifibatide and Abciximab: Outcomes, Complications and Thrombocyto

08/01/2008

Rafael Beyar , MD, DSc, MPH;

Ehud Grenadier , MD;

Walter Markiewicz , MD;

Haim Hammerman , MD;

Monther Boulus , MD;

Alexander Goldberg , MD;

Luis Gruberg , MD;

Doron Aronson , MD;

Mahmoud Suleiman , MD;

Majdi Halabi , MD;

The development of platelet glycoprotein (GP) IIb/IIIa receptor inhibitors has been a major advance in reducing ischemic complications among a broad spectrum of patients undergoing percutaneous coronary intervention (PCI).1–9 Currently, three...

The development of platelet...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Does Routine Sedation Influence Anxiety and CRP Levels in Patients Undergoing Elective Coronary Catheterization?

12/01/2021

Adi Sharabi-Nov , MD, MPH;

Zipi Regev-Avraham , PhD;

Zuheir Farraj , BSc;

Zeev Israeli , MD;

Rodrigo Bagur , MD, PhD;

Saeed Khatib , MD;

Lidia Izakson , MD;

Majdi Halabi , MD;

Elena Bukovetzky , PhD;

Soliman Khatib , PhD;

We sought to determine whether anxiety and CRP levels in patients undergoing elective left heart catheterization differ when routine sedation with midazolam is administered.

We sought to determine whether...

12/01/2021

Journal of Invasive Cardiology